Skip to main content
Silvio Inzucchi, MD, Endocrinology, New Haven, CT

SilvioEdwardInzucchiMD

Endocrinology New Haven, CT

Adrenal Disease, Diabetes, Pituitary Disorders & Neuroendocrinology

Professor of Medicine, Yale University

Telehealth Available

Overview of Dr. Inzucchi

Dr. Silvio Inzucchi is an endocrinologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Harvard Medical School and has been in practice 32 years. Dr. Inzucchi accepts several types of health insurance, listed below. He is one of 58 doctors at Yale-New Haven Hospital who specialize in Endocrinology. He has more than 100 publications and over 500 citings.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1994
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1985 - 1987
  • Harvard Medical School
    Harvard Medical SchoolClass of 1985

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1987 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2014
  • New York Magazine: Top Doctors Castle Connolly, 2007-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2006-2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial  
    Silvio Inzucchi, MD, Journal of the American Society of Nephrology
  • Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
    Erin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
  • Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
    Christina L. Fanola, Darren K. McGuire, Silvio E. Inzucchi, Erin A. Bohula, The New England Journal of Medicine

Lectures

  • Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers 
    American Heart Association, Scientific Sessions 2010, Chicago, Illinois, USA
  • Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers 
    Scientific Sessions 2008, New Orleans, Louisiana, USA
  • Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers 
    Scientific Sessions 2010, Chicago, Illinois, USA
  • Join now to see all

Other

Press Mentions

  • SGLT2 Inhibitors Cut AFib Risk in Real-Word Analysis
    SGLT2 Inhibitors Cut AFib Risk in Real-Word AnalysisJune 13th, 2022
  • SGLT2 Inhibitors Cut AFib Risk in Real-Word Analysis
    SGLT2 Inhibitors Cut AFib Risk in Real-Word AnalysisJune 13th, 2022
  • Explaining Insulin Resistance, and How to Reverse It
    Explaining Insulin Resistance, and How to Reverse ItOctober 25th, 2021
  • Join now to see all

Grant Support

  • GRADE TrialNIDDK2013–2020
  • IRIS TrialNINDS2004–2016
  • Dosage According To IGF1 Response In Growth Hormone DefiNational Center For Research Resources2000–2001
  • Effects Of Troglitazone And Metformin On Glucose MetabolismNational Center For Research Resources1996–1999
  • Ovine CRH In Evaluation Of Cushing SyndromeNational Center For Research Resources1997
  • Endocrine Evaluation Of Patients With Diseases Of The PituitaryNational Center For Research Resources1996–1997
  • Effects Of Growth Hormone Replacement In GH Deficient AdultsNational Center For Research Resources1996

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    Anthem Blue Preferred Plus POS
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Connecticare FlexPOS
    First Health PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust POS-SE
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment